2016
DOI: 10.1186/s12906-016-1424-2
|View full text |Cite
|
Sign up to set email alerts
|

The inhibitory activity of herbal medicines on the keys enzymes and steps related to carbohydrate and lipid digestion

Abstract: BackgroundObesity and overweight are consistently associated with metabolic disorders including hyperglycemia and hyperlipidemia. Herbal medicines have been currently suggested as an alternative source of potentially useful antihyperglycemic, antihyperlipidemic, antioxidant activities. The objective of this study was to assess the in vitro inhibitory effects of eleven herbal medicines on carbohydrate and lipid digestive enzymes and the key steps of lipid digestion including the inhibition of micelle formation … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
16
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(19 citation statements)
references
References 58 publications
(45 reference statements)
2
16
0
1
Order By: Relevance
“…In previous studies, alkaloids and terpenoids were reported to inhibit α-glucosidase activity and α-amylase. [26][27] Likewise, these findings synchronized with the report of Sompong et al and Riyaphan et al [28][29] in which some plants extract inhibited carbohydrate and lipid metabolism enzymes activities.…”
Section: Discussionsupporting
confidence: 82%
“…In previous studies, alkaloids and terpenoids were reported to inhibit α-glucosidase activity and α-amylase. [26][27] Likewise, these findings synchronized with the report of Sompong et al and Riyaphan et al [28][29] in which some plants extract inhibited carbohydrate and lipid metabolism enzymes activities.…”
Section: Discussionsupporting
confidence: 82%
“…& Thonn., Thunbergia laurifolia Lindl at concentration of 1 mg/mL were confirmed by investigating the inhibition not only of the pancreatic lipase activity (21.42-85.93%), but also pancreatic cholesterol esterase (2.92-53.35%), intestinal maltase (5.16-44.33%), sucrase (1.25-45.86%), and pancreatic α-amylase activity (1.75-12.53%). In addition, inhibition of the cholesterol incorporation into micelles (6.64-33.74%), as well as, the bile acids binding (2.05-18.40%) was established (Sompong et al, 2016). Among 10 investigated Asteracea species Argyranthemum pinnatifidum Lowe var.…”
Section: In Vitro Studiesmentioning
confidence: 99%
“…Current strategies for screening potent natural anti-obesity drugs involve the study of organic or water extracts of different parts (roots, leaves, fruits, flowers or seeds) of the medicinal plants, as well as, some related phytochemicals such as polyphenols, terpenoids, alkaloids, saponins, steroids and polysaccharides for their antihyperlipidemic, antihyperglycemic, carbohydrate and fat digestion reduction properties supported by their ability to modulate the molecular pathways and gene/protein expressions responsible of these activities (de Freitas Junior and de Almeida, 2017; Sompong et al, 2016;Spínola and Castilho, 2017). The suppression of the digestive enzymes, especially the pancreatic and gastric lipases, suppression of AMPK/malonyl Co-A signaling pathway or potential ghrelin antagonism that blunt the increased appetite or mediate the reduced expression of hypothalamic NPY or serum leptin (Yun, 2010), the increase of the energy expenditure via stimulating thermogenesis in muscles and BAT through the activation of UCP1 with natural compounds (Song et al, 2017b;Stohs and Badmaev, 2016) are the most widely studied mechanisms for determining natural products' beneficial effect in overweight and obese people (Sompong et al, 2016).…”
Section: Traditional Medicinal Plants As Powerful Source Of Novel Antmentioning
confidence: 99%
See 1 more Smart Citation
“…Ezzel szemben a gyógynövények α-amiláz és α-glükozidáz inhibitorainak kevésbé káros hatásai vannak (Kumar, Narwal et al 2011, Satoh, Igarashi et al 2015. Korábban számos természetes növényi eredetű antidiabetikus termékeket vizsgáltak, melyek egy része hatásos α-glikozidáz és α-amiláz inhibitor volt (Hung, Qian et al 2012, Sompong, Muangngam et al 2016. Az általunk vizsgált növényi kivonatok in vitro α-glükozidáz gátlásának középértékei μg/ml-es tartományba estek, amelyek szignifikánsan alacsonyabbak, mint a fekete tea levelek 28 mg/ml IC50 értékei (Satoh, Igarashi et al 2015) vagy a Zingiber 3 mg/ml gátló koncentrációi (Jo, Cho et al 2016), de magasabbak, mint az ayurvédikus gyógyászatban cukorbetegségben használt gyógynövény a Saliac oblongata 4 μg/ml IC50 értéke (Li, Peng et al 2004) és a Prunica granatum 1,8 μg/ml IC50 értéke (Li, Wen et al 2005).…”
Section: éRtékelésunclassified